1. Home
  2. BLDE vs GOSS Comparison

BLDE vs GOSS Comparison

Compare BLDE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • GOSS
  • Stock Information
  • Founded
  • BLDE 2014
  • GOSS 2015
  • Country
  • BLDE United States
  • GOSS United States
  • Employees
  • BLDE N/A
  • GOSS N/A
  • Industry
  • BLDE Aerospace
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLDE Consumer Discretionary
  • GOSS Health Care
  • Exchange
  • BLDE Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • BLDE 286.0M
  • GOSS 203.3M
  • IPO Year
  • BLDE N/A
  • GOSS 2019
  • Fundamental
  • Price
  • BLDE $3.59
  • GOSS $1.26
  • Analyst Decision
  • BLDE Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • BLDE 2
  • GOSS 4
  • Target Price
  • BLDE $6.25
  • GOSS $7.75
  • AVG Volume (30 Days)
  • BLDE 623.3K
  • GOSS 1.4M
  • Earning Date
  • BLDE 05-12-2025
  • GOSS 05-15-2025
  • Dividend Yield
  • BLDE N/A
  • GOSS N/A
  • EPS Growth
  • BLDE N/A
  • GOSS N/A
  • EPS
  • BLDE N/A
  • GOSS N/A
  • Revenue
  • BLDE $251,485,000.00
  • GOSS $124,590,000.00
  • Revenue This Year
  • BLDE $5.58
  • GOSS N/A
  • Revenue Next Year
  • BLDE $8.40
  • GOSS $190.37
  • P/E Ratio
  • BLDE N/A
  • GOSS N/A
  • Revenue Growth
  • BLDE 8.67
  • GOSS N/A
  • 52 Week Low
  • BLDE $2.35
  • GOSS $0.50
  • 52 Week High
  • BLDE $5.17
  • GOSS $1.55
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 62.53
  • GOSS 62.39
  • Support Level
  • BLDE $3.40
  • GOSS $1.09
  • Resistance Level
  • BLDE $3.84
  • GOSS $1.20
  • Average True Range (ATR)
  • BLDE 0.16
  • GOSS 0.09
  • MACD
  • BLDE -0.00
  • GOSS 0.01
  • Stochastic Oscillator
  • BLDE 52.93
  • GOSS 90.07

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: